Summary
Braeburn Pharmaceuticals Inc (Braeburn), an Apple Tree Partners’ portfolio company, is a specialty pharmaceutical company that develops the novel and long-acting implantable and injectable treatments for the psychiatric and neurological disorders including addiction, schizophrenia and pain. The company’s investigational product pipeline includes Probuphine, a six-month subdermal buprenorphine implant for the treatment of opioid addiction; CAM2038, a weekly and monthly subcutaneous injection depot formulation of buprenorphine for the treatment of opioid addiction and pain; risperidone implant, a six-month implant for the treatment of schizophrenia; and ATI-9242, an innovative molecule for the treatment of schizophrenia. Braeburn is headquartered in Princeton, New Jersey, the US.
Braeburn Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Braeburn Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD35 Million in Venture Financing 14
Braeburn Pharma Raises USD15 Million in Venture Financing 15
Braeburn Pharma Raises USD30 Million in Venture Financing 15
Braeburn Pharma Raises USD23.8 Million in Venture Financing 16
Braeburn Pharma Raises USD10 Million in Venture Financing 17
Braeburn Pharma Raises USD8.5 Million in Venture Financing 18
Braeburn Pharma Raises USD10 Million in Venture Financing 18
Licensing Agreements 19
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 19
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 20
Camurus Expands Licensing Agreement with Braeburn Pharma 21
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 22
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 24
Equity Offering 25
Braeburn Pharma Withdrawn IPO 25
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 27
Titan Pharma Raises USD5 Million in Private Placement of Shares 27
Braeburn Pharmaceuticals Inc - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 1
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Braeburn Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Braeburn Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD35 Million in Venture Financing 14
Braeburn Pharma Raises USD15 Million in Venture Financing 15
Braeburn Pharma Raises USD30 Million in Venture Financing 15
Braeburn Pharma Raises USD23.8 Million in Venture Financing 16
Braeburn Pharma Raises USD10 Million in Venture Financing 17
Braeburn Pharma Raises USD8.5 Million in Venture Financing 18
Braeburn Pharma Raises USD10 Million in Venture Financing 18
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 19
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 20
Camurus Expands Licensing Agreement with Braeburn Pharma 21
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 22
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 24
Braeburn Pharma Withdrawn IPO 25
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 27
Titan Pharma Raises USD5 Million in Private Placement of Shares 27
Braeburn Pharmaceuticals Inc, Key Competitors 29
Braeburn Pharmaceuticals Inc, Key Employees 30
List of Figures
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Braeburn Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
